Life Sciences

Framingham-based HeartWare International has received approval to market an implanted heart device in Canada.

Oxford Immunotec of Marlborough has developed a laboratory test that measures a patient's immunity to cytomegalovirus (CMV), a herpes virus.

Marlborough-based medical device manufacturer Boston Scientific has reached an agreement to acquire Xlumena Inc. Based in Mountain View, Calif., Xlumena makes minimally invasive devices to drain targeted areas of the gastrointestinal tract through endoscopic ultrasound. The deal is valued at $75 million and was expected to close this week, Boston Scientific (BSX) said in a statement Wednesday afternoon.

Marlborough's Ocata Therapeutics announced Tuesday a licensing agreement with Allele Biotechnology & Pharmaceuticals of San Diego.

Three Central Massachusetts life sciences companies, including one that's moving its headquarters to the region, will receive nearly $5 million in state tax incentives toward the creation of 275 jobs.

Marlborough's Ocata Therapeutics (formerly Advanced Cell Technology) reported a net loss of $34.7 million in 2014, 12 percent higher than its net loss in 2013.

Boston Scientific of Marlborough has won federal regulatory approval for an implantable medical device that helps patients at high risk for stroke, the company said.

At the end of 2005, Boston Scientific Corp. made the fateful choice to buy cardiovascular equipment company Guidant Corp. for $27 billion. Since then, repercussions from the acquisition have weighed on the Marlborough-based medical device company. But with the settlement of a lawsuit over the deal in February, the company seems to be moving forward.

Medical diagnostics firm Oxford Immunotec of Marlborough finished last year with a 19-percent year-over-year increase in revenue in the fourth quarter, part of a 28-percent jump for the entire year, the company reported Tuesday.

Boston Scientific has agreed to acquire the urology division of American Medical Systems for about $1.6 billion in cash, the Marlborough-based life sciences company announced Monday morning.